Sarepta Therapeutics, Inc.
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionSG Americas Securities, LLC
Latest Disclosed Ownership559,063 shares
Latest Disclosed Value $ 12,165
SG Americas Securities, LLC ownership in SRPT / Sarepta Therapeutics, Inc.

On April 16, 2026 - SG Americas Securities, LLC filed a 13F-HR form disclosing ownership of 559,063 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $12,165 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 9, 2026 disclosing 191,371 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 192.14% during the quarter.

SG Americas Securities, LLC has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 559,063 367,692 192.14 12 200.00 0.0131
2026-01-09 2025-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 191,371 -308,250 -61.70 4 -55.56 0.0053
2025-10-23 2025-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 499,621 462,028 1,229.03 10 0.0325
2025-08-08 2025-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 37,593 28,378 307.95 1 0.0027
2025-04-15 2025-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 9,215 8,289 895.14 1 0.0019
2025-01-17 2024-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 926 -6,267 -87.13 0 0.0005
2024-10-03 2024-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 7,193 -4,869 -40.37 1 -100.00 0.0033
2024-07-12 2024-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 12,062 6,943 135.63 2 0.0111
2024-05-06 2024-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 5,119 5,119 1 0.0032
2023-07-10 2023-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -14,144 -100.00 0 -100.00
2023-04-28 2023-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 14,144 6,544 86.11 2 0.0227
2023-02-02 2022-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 7,600 7,600 1 0.0120
2022-10-31 2022-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -51,064 -100.00 0 -100.00
2022-07-29 2022-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 51,064 29,396 135.67 3,828 126.11 0.0407
2022-04-29 2022-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 21,668 21,668 1,693 0.0124
2022-02-07 2021-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -3,032 -100.00 0 -100.00
2021-11-01 2021-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 3,032 -5,434 -64.19 280 -57.45 0.0013
2021-08-12 2021-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 8,466 -8,552 -50.25 658 -48.11 0.0031
2021-05-13 2021-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 17,018 9,448 124.81 1,268 -1.78 0.0066
2021-02-04 2020-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 7,570 -24,901 -76.69 1,291 -71.69 0.0069
2020-11-09 2020-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 32,471 27,509 554.39 4,560 472.86 0.0290
2020-07-20 2020-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 4,962 -43,303 -89.72 796 -83.14 0.0066
2020-04-30 2020-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 48,265 48,265 4,721 0.0443
2020-01-28 2019-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -2,412 -100.00 0 -100.00
2019-11-04 2019-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 2,412 943 64.19 182 -18.39 0.0015
2019-07-29 2019-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 1,469 -4,042 -73.34 223 -66.06 0.0015
2019-04-29 2019-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 5,511 561 11.33 657 21.67 0.0060
2019-01-31 2018-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 4,950 3,451 230.22 540 123.14 0.0047
2018-11-06 2018-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 1,499 1,499 242 0.0018
2018-08-07 2018-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -4,386 -100.00 0 -100.00
2018-05-03 2018-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 4,386 1,952 80.20 325 140.74 0.0026
2018-01-24 2017-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 2,434 -5,866 -70.67 135 -64.10 0.0013
2017-11-07 2017-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 8,300 8,300 376 0.0033
2017-08-03 2017-06-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -4,706 -100.00 0 -100.00
2017-05-10 2017-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 4,706 -29,169 -86.11 139 -85.04 0.0012
2017-02-08 2016-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 33,875 26,816 379.88 929 114.55 0.0078
2017-02-08 2016-09-30 13F/A-1 SAREPTA THERAPEUTICS INC COM COM 803607100 7,059 7,059 433 0.0045
2016-11-08 2016-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 7,059 433
2016-05-12 2016-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 0 0 0.0000
2016-02-12 2015-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -10,036 -100.00 0 -100.00
2015-11-09 2015-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 10,036 10,036 0.00 322 0.0019
2015-05-13 2015-03-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -10,251 -100.00 0 -100.00
2015-02-12 2014-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 10,251 10,251 -46.72 148 -83.72 0.0007
2014-02-12 2013-12-31 13F SAREPTA THERAPEUTICS INC COM COM 803607100 0 -19,240 -100.00 0 -100.00
2013-11-12 2013-09-30 13F SAREPTA THERAPEUTICS INC COM COM 803607100 19,240 19,240 909 0.0037
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-07-10 2023-06-30 13F SAREPTA THERAPEUTICS OPT Call 0 -100.00 0 n/a n/a n/a
2023-04-28 2023-03-31 13F SAREPTA THERAPEUTICS OPT Call 72,800 0 n/a n/a n/a
2022-10-31 2022-09-30 13F SAREPTA THERAPEUTICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-07-29 2022-06-30 13F SAREPTA THERAPEUTICS OPT Call 75,000 398 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-02-04 2020-12-31 13F SAREPTA THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-09 2020-09-30 13F SAREPTA THERAPEUTICS OPT Put 22,000 308 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.